Cory Watson Attorneys Product Liability Talcum Powder Cancer
$4.7 Billion Verdict Against Johnson & Johnson in Talcum Powder Lawsuit
July 17th, 2018 | Talcum powder cancer
$4.7 Billion Talcum Powder Verdict Against Johnson & Johnson On July 12, 2018, a St. Louis jury awarded a $4.7 billion verdict to 22 women who say Johnson & Johnson’s talc-based products gave them ovarian cancer. The women accused the company of failing to warn them about the cancer risks associated with its popular baby powders. […]Read More
$4.69 Billion Verdict for Johnson & Johnson In Talcum Powder Lawsuit
July 12th, 2018 | Talcum powder cancer
$4.69 Billion Verdict for Johnson & Johnson In Talcum Powder Lawsuit Johnson & Johnson was hit with a multi-billion dollar talcum powder verdict on Thursday, one that marked one of the largest product liability verdicts in the nation’s history. The company was ordered to pay $4.69 billion to 22 women and their families, who claimed […]Read More
There Are Still Products On The Market Containing Asbestos
January 11th, 2018 | Talcum powder cancer
Products Still On The Market Containing Asbestos It has been common knowledge for years now that asbestos can directly cause numerous cancers, such as cancers of the lung, larynx, and ovaries, as well as mesothelioma. Because of that, it’s easy to assume that the substance is banned and not allowed for any type of use […]Read More
Did Johnson & Johnson Really Know About Talc Decades Ago?
October 2nd, 2017 | Talcum powder cancer
Did Johnson & Johnson Know About Talc Decades Ago? Recent trials have revealed that Johnson & Johnson long knew about the link between talcum powder and ovarian cancer, but newly released documents from a current trial in St. Louis, Missouri, suggest that the pharmaceutical giant also knew that the talc it used in its baby […]Read More
Johnson & Johnson Reeling After $417 Million Verdict In California
August 21st, 2017 | Talcum powder cancer
Johnson & Johnson Reeling After $417 Million Verdict In California The first court case in California against Johnson & Johnson for its talc products associated with ovarian cancer resulted in a massive payout against the pharmaceutical giant. The four-week trial resulted in the Los Angeles jury siding with Eva Echeverria, a 63-year-old woman with terminal […]Read More
Johnson & Johnson Hit Again With A $110 Million Verdict
May 6th, 2017 | Talcum powder cancer
Johnson & Johnson Hit Again With A $110 Million Verdict Another week, another verdict against Johnson & Johnson for its talc-based products and their link to ovarian cancer. This week a St. Louis, Missouri, jury awarded $110.5 million to a Virginia woman who sued Johnson & Johnson, along with its talc supplier Imerys Talc, claiming […]Read More
Johnson & Johnson Takes Third Loss in Latest Ovarian Cancer Trial
October 27th, 2016 | Talcum powder cancer
Johnson & Johnson Takes Third Loss in Latest Ovarian Cancer Trial Johnson & Johnson has now lost three court cases in a row regarding its talcum powder products and their link to ovarian cancer. Today a St. Louis jury awarded $70 million to 63-year-old Deborah Giannecchini, who claims her ovarian cancer was caused by her […]Read More
Pharmaceutical Giant Receives Second Loss in One Week
May 3rd, 2016 | Talcum powder cancer
Pharmaceutical Giant Receives Second Loss in One Week Johnson & Johnson received its second straight trial loss this week as jurors once again found the company liable for a woman who used the company’s baby powder for decades and developed ovarian cancer. After the three-week trial in a Missouri court, the pharmaceutical company was ordered […]Read More
Alabama Woman Gets $72 Million From Johnson & Johnson
February 24th, 2016 | Talcum powder cancer
Alabama Woman Gets $72 Million From Johnson & Johnson The first case with monetary compensation against Johnson & Johnson was awarded in a St. Louis, Missouri, courtroom last week. Jacqueline Fox, a resident of Birmingham, Alabama, had already passed away, but her voice spoke volumes in the courtroom. During a previously recorded audio deposition, Fox […]Read More